2005•Shandong yiyaoRequires access

Study of the early use of noninvasive positive-pressive ventilationin acute exacerbations of COPD

Mao-fen Wang

Open publisher page 0 citations

Abstract

Objective: To estimate the early use of noninvasive positive-pressure ventilation (NIPPV) in acute exacerbations of COPD.Methods: 90 COPD cases with hypercapnia were involved in the study.The patients were randomized into two groups (BiPAP and standard-therapy group).Standard-therapy group was control group.All the cases were recorded blood gas analysis at beginning and in 2, 24, 48, 72 and 7d respectively.Results: The groups had similar clinical characteristics and gas exchange at the beginning of trial.PaCO_2 was significantly decreased in BiPAP group in the trial.Compared with standard-therapy group, BiPAP also lowered the rate of endotracheal intubation (P0.05) and the lenth of hospital stay (P0.01).There is no difference in hospital mortality.Conclusion: The early application of NIPPV (BiPAP) to standard medical therapy does improve blood gas outcome in patients who develop hypercapnia and lower the rate of endotracheal intubation and the lenth of hospital stay.

About this research paper

What this paper is about

Objective: To estimate the early use of noninvasive positive-pressure ventilation (NIPPV) in acute exacerbations of COPD.Methods: 90 COPD cases with hypercapnia were involved in the study.The patients were randomized into two groups (BiPAP and standard-therapy group).Standard-therapy group was control group.All the cases were recorded blood gas analysis at beginning and in 2, 24, 48, 72 and 7d respectively.Results: The groups had similar clinical characteristics and gas exchange at the beginning of trial.PaCO_2 was significantly decreased in BiPAP group in the trial.Compared with standard-therapy group, BiPAP also lowered the rate of endotracheal intubation (P0.05) and the lenth of hospital stay (P0.01).There is no difference in hospital mortality.Conclusion: The early application of NIPPV (BiPAP) to standard medical therapy does improve blood gas outcome in patients who develop hypercapnia and lower the rate of endotracheal intubation and the lenth of hospital stay.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To estimate the early use of noninvasive positive-pressure ventilation (NIPPV) in acute exacerbations of COPD.Methods: 90 COPD cases with hypercapnia were involved in the study.The patients were randomized into two groups (BiPAP and standard-therapy group).Standard-therapy group was control group.All the cases were recorded blood gas analysis at beginning and in 2, 24, 48, 72 and 7d respectively.Results: The groups had similar clinical characteristics and gas exchange at the beginning of trial.PaCO_2 was significantly decreased in BiPAP group in the trial.Compared with standard-therapy group, BiPAP also lowered the rate of endotracheal intubation (P0.05) and the lenth of hospital stay (P0.01).There is no difference in hospital mortality.Conclusion: The early application of NIPPV (BiPAP) to standard medical therapy does improve blood gas outcome in patients who develop hypercapnia and lower the rate of endotracheal intubation and the lenth of hospital stay.

Key concepts: Medicine, Hypercapnia, COPD, Anesthesia, Intubation, Randomized controlled trial, Endotracheal intubation, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of the early use of noninvasive positive-pressive ventilationin acute exacerbations of COPD — Research Paper | ScholarLens